Brief: The Oncology Institute Reaffirms 2025 Guidance And Provides Preliminary 2026 Outlook
12/01/2026 13:16
Jan 12 (Reuters) - Oncology Institute Inc TOI.O: THE ONCOLOGY INSTITUTE REAFFIRMS 2025 GUIDANCE AND PROVIDES PRELIMINARY 2026 OUTLOOK ONCOLOGY INSTITUTE INC - ANTICIPATES 2026 REVENUE BETWEEN $630 MILLION AND $650 MILLION ONCOLOGY INSTITUTE INC: LOOKING BEYOND 2026, CO IS WELL POSITIONED FOR CONTINUED EXPANSION Source text: ID:nGNXbXwg8q Further company coverage: TOI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncology Institute
See all newsOncology Institute Q1 revenue rises on specialty pharmacy growth, reaffirms 2026 revenue guidance
Brief: Oncology Institute Q1 Gross Profit USD 23.3 Million
Oncology Institute beats Q4 revenue estimates, net loss narrows
Brief: The Oncology Institute Reaffirms 2025 Guidance And Provides Preliminary 2026 Outlook
Brief: The Oncology Institute Announces Leadership Promotions